期刊文献+

超声微泡介导hVEGF165基因靶向转染糖尿病鼠缺血骨骼肌

Ultrasound-mediated Microbubbles Destruction Enhanced h VEGF165 Gene Expression in Ischemic Skeletal Muscle of Diabetic Rats
原文传递
导出
摘要 目的:探讨超声介导微泡破裂法促进血管内皮生长因子(VEGF)基因在糖尿病鼠缺血骨骼肌内转染的作用,评估其转染效率和安全性。方法:建立糖尿病鼠缺血骨骼肌动物模型,以绿色荧光蛋白基因为报告基因,观察接受超声及微泡治疗组h VEGF165基因在糖尿病鼠缺血骨骼肌内表达,并与对照组相比。同时取糖尿病鼠缺血骨骼肌进行HE染色行组织学检查。结果:在超声介导微泡破裂组内,h VEGF165基因表达明显增强(42.87±5.12),与单纯接受质粒治疗组(5.02±1.21)和接受质粒和超声治疗组(8.16±2.43)相比,差异具有统计学意义(P<0.001),HE切片未发现肌组织结构的改变。结论:超声介导微泡破裂法能有效促进外源基因在糖尿病鼠缺血骨骼肌中表达,为糖尿病周围血管疾病的基因治疗提供了实验依据。 Objective: To evaluate the efficiency and safety of the method of ultrasound-mediated microbubbles destruction to enhance vascular endothelial growth factor(VEGF) gene transfecting in ischemic skeletal muscle of diabetic rat. Methods: To establish an animal model of ischemic skeletal muscle in diabetic rat, green fluorescent protein as reporter gene, observe h VEGF165 gene expression in ischemic skeletal muscle in diabetic mice in different group, and histological study of skeletal muscle was performed after experiments to evaluate the potential effects of gene transfer. Results: In the ultrasound-mediated microbubbles destruction group,h VEGF165 gene expression was significantly increased(42.87±5.12) and compared with the other two groups(5.02±1.21, 8.16±2.43,respective), the difference was statistically significant(P〈0.001), whereas the histological analyses did not reveal harmful effect.Conclusion: The method of ultrasound-mediated microbubbles destruction can effectively promote h VEGF165 gene expression in ischemic skeletal muscle in diabetic mice, and this method provides an experimental basis for gene therapy of diabetic peripheral vascular disease.
出处 《现代生物医学进展》 CAS 2015年第36期7009-7011,7131,共4页 Progress in Modern Biomedicine
基金 黑龙江省青年科学基金项目(QC2010090)
关键词 多普勒超声 微泡 基因 血管内皮生长因子 Ultrasound Microbubble Gene Vascular endothelial growth factor
  • 相关文献

参考文献22

  • 1Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis [J]. Lancet, 2013, 382 (9901): 1329-1340.
  • 2Criqui M H, Alberts M J, Fowkes F G, et al. American Heart Association Writing Group 2. Atherosclerotic Peripheral Vascular Disease Symposium Ⅱ: screening for atherosclerotic vascular diseases: should nationwide programs be instituted [J]. Circulation, 2008, 118(25): 2830-2836.
  • 3Lovell M, Harris K, Forbes T, et al. on behalf of the Peripheral Arterial Disease Coalition. Peripheral arterial disease: lack of awareness in Canada[J]. Can. J. Cardiol, 2009, 25(1): 39-45.
  • 4Kusumanto YH, Weel VV, Mulder NH, et al. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trail [J]. Hum Gene Ther, 2006, 17 (6): 683-691.
  • 5Hideki Amano, Shintaro Kato, Yoshiya Ito, et al. The role of vascular endothelial growth factor receptor-1 signaling in the recovery from ischemia[J]. PLoS One, 2015, 10(7): e0131445.
  • 6Li X, Gan K, Song G, et al. VEGF gene transfected umbilical cord mesenchymal stem cells transplantation improve the lower limb vascular lesions of diabetic rats [J]. J Diabetes Complications, 2015, 29(7): 872-881.
  • 7Awada HK, Johnson NR, Wang Y. Sequential delivery of angiogenic growth factors improves revascularization and heart function after myocardial infarction[J]. J Control Release, 2015, 10(207): 7-17.
  • 8Verma IM, Somia N. Gene therapy: promises, problems and prospects [J]. Nature, 1997, 389(6648): 239-242.
  • 9Liang RF, Zheng LL. The efficacy and safety of panitumumab in the treatment of patients with metastatic colorectal cancer: a meta-analysis from five randomized controlled trims [J]. Drug Des Devel Ther, 2015,7(9): 4471-4478.
  • 10Mason D, Chen YZ, Krishnan HV, et al. Cardiac gene therapy: Recent advances and future directions [J]. J Control Release, 2015, 5 (215): 101-111.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部